切换至 "中华医学电子期刊资源库"
高级检索
中华普通外科学文献(电子版)

中华普通外科学文献(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 331 -335. doi: 10.3877/cma.j.issn.1674-0793.2021.05.003

论著

胰头癌患者术后预后评价及相关危险因素分析
徐俊明1, 张欣雪1, 曹爽1, 刘喆1, 马军1, 寇建涛1, 贺强1,†()   
  1. 1. 100020　首都医科大学附属北京朝阳医院肝胆外科
  • 收稿日期:2021-05-13 出版日期:2021-09-28
  • 通信作者: 贺强

Evaluation of postoperative prognosis and related risk factors in patients with pancreatic head cancer

Junming Xu1, Xinxue Zhang1, Shuang Cao1, Zhe Liu1, Jun Ma1, Jiantao Kou1, Qiang He1,†()   

  1. 1. Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital Affiliated to Capital Medical University, Beijing 100020, China
  • Received:2021-05-13 Published:2021-09-28
  • Corresponding author: Qiang He
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

徐俊明, 张欣雪, 曹爽, 刘喆, 马军, 寇建涛, 贺强. 胰头癌患者术后预后评价及相关危险因素分析[J]. 中华普通外科学文献(电子版), 2021, 15(05): 331-335.

Junming Xu, Xinxue Zhang, Shuang Cao, Zhe Liu, Jun Ma, Jiantao Kou, Qiang He. Evaluation of postoperative prognosis and related risk factors in patients with pancreatic head cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2021, 15(05): 331-335.

目的

评价胰头癌患者行根治性手术的预后情况，并分析影响预后的相关因素，为提高胰头癌患者生存率提供借鉴。

方法

回顾性分析首都医科大学附属北京朝阳医院2015年1月至2019年12月连续收治的167例可切除或交界可切除胰头癌患者的临床资料及随访情况，采用Kaplan-Meier法绘制生存曲线，生存率比较采用Log-rank检验，多因素Cox回归分析预后影响因素，以X-tile软件计算淋巴结参数的最佳截断值。

结果

167例患者均顺利完成手术，其中围手术期死亡2例（1.2%），其余患者均获随访。术后总体中位生存时间17个月，1、2、3年总体生存率分别为59.3%、36.5%、25.2%。肿瘤低分化（HR=1.708，95% CI：1.147~2.543）和淋巴结阳性率>0.1（HR=2.029，95% CI：1.069~3.853）是影响胰头癌患者预后的独立危险因素。

结论

胰头癌患者行根治性手术预后较好。肿瘤分化程度越低、淋巴结阳性率越高的胰头癌患者预后越差，淋巴结阳性率对于预后的预测优于单纯的淋巴结阳性数。

关键词: 胰头肿瘤, 胰十二指肠切除术, TNM分期, 淋巴结清扫, 淋巴结阳性率, 肿瘤分化, 预后
Objective

To evaluate the prognosis of patients with pancreatic head cancer undergoing radical surgery, and to analyze the related factors affecting the prognosis, in order to provide reference for improving the survival rate.

Methods

The clinical data and follow-up of 167 patients with resectable or borderline resectable pancreatic head cancer admitted to Beijing Chaoyang Hospital Affiliated to Capital Medical University from January 2015 to December 2019 were retrospectively analyzed. Kaplan-Meier method plotted the survival curve, Log-rank test was used for survival comparison, Multivariate Cox regression was used to analyze the prognostic factors, and the best cut-off value of lymph node parameters was calculated by X-tile software.

Results

All the patients successfully completed the operation, 2 cases (1.2%) died during the perioperative period, and the other patients were followed up. The overall median survival time was 17 months. The 1-, 2- and 3-year overall survival rates were 59.3%, 36.5% and 25.2% respectively. Low tumor differentiation (HR=1.708, 95% CI: 1.147-2.543) and lymph node positive rate > 0.1 (HR=2.029, 95% CI: 1.069-3.853) were independent risk factors affecting the prognosis of patients with pancreatic head cancer.

Conclusions

The prognosis of patients with pancreatic head cancer undergoing radical surgery is better. The lower the degree of tumor differentiation and the higher the positive rate of lymph nodes, the worse the prognosis. Moreover, the predictive value of lymph node positive rate for prognosis is better than that of lymph node positive number.

Key words: Pancreatic head carcinoma, Pancreatoduodenectomy, TNM classification, Lymph node dissection, Lymph node positive rate, Tumor differentiation, Prognosis
图1 胰头癌患者术后总体生存曲线
表1 影响根治性胰十二指肠切除胰头癌患者预后的单因素分析(%)
因素 例数 1年生存率 2年生存率 3年生存率 χ2值 P值
性别         4.194 0.041
  男 92 54.0 26.7 19.0    
  女 75 59.0 44.4 30.0    
年龄(岁)         0.282 0.595
  ≤60 63 65.9 40.4 24.9    
  >60 104 50.3 30.9 24.1    
症状         0.405 0.525
  有 142 68.0 47.7 26.5    
  无 25 54.1 32.1 23.4    
吸烟史         3.004 0.083
  有 50 53.6 21.2 12.3    
  无 117 57.5 40.5 29.0    
糖尿病史         0.384 0.535
  有 54 61.0 35.3 24.2    
  无 113 54.2 34.4 24.0    
AST(U/L)         0.151 0.697
  ≤35 61 59.8 33.7 28.6    
  >35 106 54.3 35.4 21.4    
ALT(U/L)         0.151 0.697
  ≤40 61 59.6 33.0 27.7    
  >40 106 54.5 35.7 22.1    
ALB(g/L)         3.902 0.048
  ≥40 35 63.6 49.4 27.8    
  <40 132 54.5 31.4 23.4    
TBIL(μmol/L)         1.378 0.240
  ≥21 110 55.7 34.6 23.0    
  <21 57 57.9 34.8 27.4    
CEA(μg/L)         7.706 0.006
  ≤5 126 62.3 39.5 28.9    
  >5 41 39.0 20.7 10.6    
CA19-9(U/ml)         3.964 0.046
  ≤37 32 60.5 48.5 43.1    
  >37 135 55.3 31.7 20.9    
术前减黄         1.729 0.189
  是 43 49.4 31.4 26.9    
  否 124 58.5 35.7 23.8    
肿瘤分化程度         4.846 0.028
  低 57 41.8 22.1 16.8    
  中-高 110 67.5 43.4 29.2    
静脉侵犯         1.385 0.239
  有 82 50 32.9 21.5    
  无 85 62.4 36.9 27.1    
T分期         6.712 0.035
  T1 35 75.1 57.9 37.2    
  T2 99 56.2 32.0 23.7    
  T3 33 37.9 19.0 12.6    
淋巴结清扫数(个)         0.166 0.684
  <29 119 57.0 36.3 23.1    
  ≥29 48 54.5 30.0 26.7    
淋巴结阳性数(个)         17.491 <0.001
  0 50 76.7 55.7 39.6    
  1~2 46 61.9 44.0 31.0    
  ≥3 71 38.7 13.5 9.0    
N分期         15.107 0.001
  N0 50 76.7 55.7 39.6    
  N1 64 54.7 37.8 25.6    
  N2 53 39.6 11.5 8.6    
淋巴结阳性率         21.607 <0.001
  0 50 76.7 55.7 39.6    
  <0.1 40 69.4 53.9 27.3    
  ≥0.1 77 36.9 13.6 7.8    
表2 影响根治性胰十二指肠切除胰头癌患者预后的Cox回归分析
因素 HR值 95% CI P值
性别 1.250 0.852~1.835 0.255
术前白蛋白 0.725 0.434~1.211 0.219
术前CEA 1.361 0.889~2.083 0.157
术前CA19-9 0.936 0.553~1.584 0.806
肿瘤分化程度 1.708 1.147~2.543 0.008
T分期 1.350 0.982~1.857 0.064
N分期 0.822 0.428~1.577 0.555
淋巴结阳性数 1.612 0.825~3.151 0.162
淋巴结阳性率 2.029 1.069~3.853 0.031
图2 不同分化程度胰头癌患者根治术后的生存曲线
图3 不同淋巴结阳性率胰头癌患者根治术后的生存曲线
[1]
张太平, 徐建威, 赵玉沛. 胰头癌的外科治疗:理念变革与争议[J/CD].中华肝脏外科手术学电子杂志, 2014, 3(6): 334-337.
[2]
McGuigan A, Kelly P, Turkington RC, et al. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes[J]. World J Gastroenterol, 2018, 24(43): 4846-4861.
[3]
Feng M, Cao Z, Sun Z, et al. Pancreatic head cancer: open or minimally invasive pancreaticoduodenectomy?[J]. Chin J Cancer Res, 2019, 31(6): 862-877.
[4]
Gilabert M, Boher JM, Raoul JL, et al. Comparison of preoperative imaging and pathological findings for pancreatic head adenocarcinoma: A retrospective analysis by the Association Française de Chirurgie[J]. Medicine (Baltimore), 2017, 96(24): e7214.
[5]
Yang SJ, Hwang HK, Kang CM, et al. Preoperative defining system for pancreatic head cancer considering surgical resection[J]. World J Gastroenterol, 2016, 22(26): 6076-6082.
[6]
Feng F, Cao X, Liu X, et al. The effect of pancreatoduodenectomy plus intraperitoneal hyperthermic perfusion on resectable pancreatic head cancer: cohort study[J]. Ann Surg Oncol, 2021, 28(4): 2337-2345.
[7]
Jang JY, Kang MJ, Heo JS, et al. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer[J]. Ann Surg, 2014, 259(4): 656-664.
[8]
彭洋, 孙韶龙, 王宝胜, 等. 胰头癌根治术后患者预后相关因素分析[J]. 现代肿瘤医学, 2018, 26(24): 3982-3985.
[9]
李皇保, 周俊, 吴晓俊, 等. 胰头癌手术患者的预后因素:基于SEER数据库的回顾性研究[J]. 中华肝胆外科杂志, 2018, 24(2): 104-108.
[10]
Perysinakis I, Avlonitis S, Georgiadou D, et al. Five-year actual survival after pancreatoduodenectomy for pancreatic head cancer[J]. ANZ J Surg, 2015, 85(3): 183-186.
[11]
杜汉朋, 陈伟, 黄力, 等. 胰十二指肠切除术联合血管切除重建的应用及疗效[J/CD]. 中华普通外科学文献（电子版）, 2018, 12(4): 233-237.
[12]
方乐平, 徐晓燕, 姬玉, 等. 胰腺癌术后影响患者预后的相关因素分析[J]. 中华医学杂志, 2018, 98(8): 606-611.
[13]
任虎, 王成锋. 淋巴结转移指标与R0切除胰腺癌患者预后的关系[J]. 中华肿瘤杂志, 2020, 42(6): 474-479.
[14]
Morales-Oyarvide V, Rubinson DA, Dunne RF, et al. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival[J]. Br J Cancer, 2017, 117(12): 1874-1882.
[15]
Kwon W, He J, Higuchi R, et al. Multinational validation of the American Joint Committee on Cancer 8th edition pancreatic cancer staging system in a pancreas head cancer cohort[J]. J Hepatobiliary Pancreat Sci, 2018, 25(9): 418-427.
[16]
You MS, Lee SH, Choi YH, et al. Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment[J]. BMC Cancer, 2019, 19(1): 952.
[17]
La Torre M, Nigri G, Petrucciani N, et al. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes[J]. Pancreatology, 2014, 14(4): 289-294.
[18]
Tol JA, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)[J]. Surgery, 2014, 156(3): 591-600.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[3] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[4] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[5] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[6] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[7] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[8] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[9] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[10] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[11] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[12] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号